-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
Taysha Gene Therapies, Inc. quarterly/annual Revenues history and growth rate from Q1 2023 to Q3 2024.
- Taysha Gene Therapies, Inc. Revenues for the quarter ending September 30, 2024 was $1.79M, a 62.3% decline year-over-year.
- Taysha Gene Therapies, Inc. Revenues for the twelve months ending September 30, 2024 was $9.92M.
- Taysha Gene Therapies, Inc. annual Revenues for 2023 was $15.5M, a 518% increase from 2022.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)